
DURHAM, N.C., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it will release its fourth quarter and full year 2025 financial results before the market opens on Thursday, February 26, 2026. Fortrea will host a conference call at 8:00 am ET that day to review its financial results and conduct a question-and-answer session.
To participate in the earnings call, participants should register online at the Fortrea Investor Relations website. To avoid potential delays, please join at least 10 minutes prior to the start of the call. The conference call can also be accessed through the following earnings webcast link.
A replay of the live conference call will be available shortly after the conclusion of the event and accessible on the events and presentations section of the Fortrea Investor Relations website.
About Fortrea
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology and consulting services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team working in about 100 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com and follow us on LinkedIn and X (formerly Twitter).
Fortrea Contacts
Tracy Krumme (Investors) – 984-385-6707, tracy.krumme@fortrea.com
Sue Zaranek (Media) – 919-943-5422, media@fortrea.com
Kate Dillon (Media) – 646-818-9115, kdillon@prosek.com
随机文章
热门文章

V1.0重磅发布!四维天穹绘构低空天路
Merck Appoints David Weinreich as New Global Head of R&D and Chief Medical Officer for Healthcar
“兴火·燎原”总冠军诞生,云宏信息《金融高算力轻量云平台》登顶
泳池过滤器怎么选?揭开Waternics水武仕珍珠岩过滤器的“硬核密码”!
Graco推出QUANTM电动双隔膜泵系列的改进产品
2025上海CMEF:鱼跃以“AI+医疗”开启健康管理新纪元
再获殊荣!itc分布式综合管理平台荣获2024年度“分布式处理十大品牌”
北京爱育华医院耳鼻喉头颈外科高品质服务升级
交个朋友严选背后:为何是蛰伏三年的酃酃酒